Sharkey, Howes & Javer’s VanEck Biotech ETF BBH Stock Holding History

Sharkey, Howes & Javer’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-346	Closed	-$36K	–	248
2016 Q1	$36K	Hold	346	–	–	0.03%	108
2015 Q4	$44K	Hold	346	–	–	0.03%	102
2015 Q3	$46K	Hold	346	–	–	0.04%	96
2015 Q2	$47K	Buy	+346	New	+$46K	0.04%	75

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.28B AUM 22.9% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Sharkey, Howes & Javer's BBH Position: Q2 2016 in Review

Sharkey, Howes & Javer sold out of VanEck Biotech ETF (BBH) in Q2 2016, closing a stake of 346 shares — an estimated $36K sold.

Sharkey, Howes & Javer first reported a position in BBH in Q2 2015 and held it in 4 quarters. The position peaked at $47K in Q2 2015. 78 funds tracked by Wall St. Rank hold BBH as of Q2 2016.

Sharkey, Howes & Javer reported no remaining VanEck Biotech ETF position as of Q2 2016 after selling out during the quarter.
Sharkey, Howes & Javer sold 346 VanEck Biotech ETF shares in Q2 2016, an estimated $36K.
Sharkey, Howes & Javer first reported a position in VanEck Biotech ETF in Q2 2015 and held it in 4 quarters.
Sharkey, Howes & Javer's VanEck Biotech ETF position peaked at $47K in Q2 2015.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2016.

Based on Sharkey, Howes & Javer's 13F filing for Q2 2016, filed 5 Aug 2016.